2m 2m 2m 2m 2m 2m 2m
Emergent BioSolu (EBS)
NYSE
$5.99-$0.05 (-0.76%)
Price as of Nov 12, 2026 8:07 AM EST- $310.5MMarket Cap
- -44.13%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Emergent BioSolu (EBS)
$5.99-$0.05 (-0.76%)
EBS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.04 | ||
Change | -$0.010 (-0.17%) | ||
Open | $6.06 | ||
High | $6.12 | ||
Low | $6.00 | ||
Previous Close | $6.05 | ||
Volume | 516,166 | ||
30-Day Average Volume | 1,082,572 | ||
1-Week Change | 2.37% | ||
1-Month Change | -14.45% | ||
1-Year Change | -44.13% | ||
3-Year Change | 202.00% | ||
5-Year Change | -82.96% | ||
Fundamentals | |||
Shares Outstanding | 51.4M | ||
Total Assets | $995.2M | ||
Market Cap | $310.5M | ||
Enterprise Value | $642.5M | ||
Period: QTR TTM FY | |||
Revenue | $106.4M | ||
Net Income | -$32.7M | ||
Free Cash Flow | $96.8M | ||
EBIT | -$36.4M | ||
EBITDA | -$19.4M | ||
Net Working Capital | $436.2M | ||
EPS | -$0.64 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | 3 | ||
Price/Operating Cash Flow | 3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue